Page last updated: 2024-08-22

camptothecin and valproic acid

camptothecin has been researched along with valproic acid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Gupta, E; Ramirez, J; Ratain, MJ; Wang, X1
de Jong, FA; Kitzen, JJ; Loos, WJ; Mathijssen, RH; Mathôt, RA; van den Bent, MJ; van der Bol, JM; Verweij, J1
Hormozi, L; Parker, L; Song, J; Tanouye, MA1
Bastien, S; Bicaku, E; Daud, AI; Dawson, J; DeConti, RC; Hausheer, FA; Lush, R; Marchion, D; Munster, PN; Neuger, A; Sullivan, DM1
Aiba, K; Arakawa, Y; Saito, S; Yamada, H1
Coy, DH; Fuselier, JA; Mackey, LV; Qian, Q; Sun, G; Sun, L; Yu, CY1
Guo, GL; Schumacher, JD1
Fan, L; Jiang, T; Qiu, X; Yin, Y; Zhu, Q1
Chen, Y; Dai, Y; Ye, T; Zhang, Y1

Reviews

1 review(s) available for camptothecin and valproic acid

ArticleYear
Mechanistic review of drug-induced steatohepatitis.
    Toxicology and applied pharmacology, 2015, Nov-15, Volume: 289, Issue:1

    Topics: Amiodarone; Animals; Camptothecin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fatty Liver; Hepatocytes; Humans; Irinotecan; Lipid Metabolism; Liver; Methotrexate; Mitochondria, Liver; Organoplatinum Compounds; Oxaliplatin; Perhexiline; Tamoxifen; Tetracycline; Valproic Acid

2015

Trials

1 trial(s) available for camptothecin and valproic acid

ArticleYear
Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-01, Volume: 15, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Drug Synergism; Enzyme Inhibitors; Female; Histone Deacetylase Inhibitors; Histones; Humans; Male; Melanoma; Mice; Mice, Nude; Middle Aged; Skin Neoplasms; Topoisomerase I Inhibitors; Valproic Acid

2009

Other Studies

8 other study(ies) available for camptothecin and valproic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Modulation of glucuronidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbital.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biotransformation; Camptothecin; Female; Glucuronates; Glucuronosyltransferase; Irinotecan; Metabolic Clearance Rate; Phenobarbital; Rats; Rats, Wistar; Valproic Acid

1997
Irinotecan chemotherapy during valproic acid treatment: pharmacokinetic interaction and hepatotoxicity.
    Cancer biology & therapy, 2007, Volume: 6, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chromatography, High Pressure Liquid; Female; Glucuronates; Glucuronosyltransferase; Humans; Irinotecan; Liver; Middle Aged; Models, Biological; Transaminases; Treatment Outcome; Valproic Acid

2007
DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy.
    Neuroscience, 2008, Oct-15, Volume: 156, Issue:3

    Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Bromates; Camptothecin; Disease Models, Animal; DNA Topoisomerases, Type I; Drosophila; Drosophila Proteins; Drug Administration Schedule; Electric Stimulation; Electroshock; Enzyme Inhibitors; Epilepsy; Evoked Potentials; Motor Neurons; Muscle, Skeletal; Mutation; Paralysis; Seizures; Topoisomerase I Inhibitors; Valproic Acid

2008
Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-X(L) and promotes apoptosis of MCF-7 breast cancer cells.
    Apoptosis : an international journal on programmed cell death, 2009, Volume: 14, Issue:9

    Topics: Apoptosis; bcl-X Protein; Breast Neoplasms; Camptothecin; Caspase 3; Cell Cycle; Cell Line, Tumor; Drug Synergism; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Immunoblotting; Membrane Potential, Mitochondrial; RNA, Small Interfering; Valproic Acid

2009
Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
    Journal of drug targeting, 2016, Volume: 24, Issue:2

    Topics: Animals; Apoptosis; Camptothecin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Mice; Mice, Nude; Neuroendocrine Tumors; Pancreatic Neoplasms; Peptides; Receptors, Notch; Receptors, Peptide; Receptors, Somatostatin; Repressor Proteins; Signal Transduction; Valproic Acid

2016
Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment.
    Science China. Life sciences, 2019, Volume: 62, Issue:8

    Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; DNA Damage; Drug Therapy, Combination; Etoposide; Gamma Rays; Histone Deacetylase Inhibitors; Histones; Homeostasis; Humans; Hydroxamic Acids; Methyl Methanesulfonate; Mice; Valproic Acid; Vorinostat

2019
Synthesis and Antitumor Evaluation of Biotin-SN38-Valproic Acid Conjugates.
    Molecules (Basel, Switzerland), 2023, May-07, Volume: 28, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biotin; Camptothecin; Cell Line, Tumor; Fibroblasts; HeLa Cells; Humans; Irinotecan; Mice; NIH 3T3 Cells; Valproic Acid

2023